BIOEOS LIMITED

Company number 05175852 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£162,492

Balance sheet as at 2026-01-31

View full accounts →

What it does

The Company is principally engaged in research into and commercial development of immune-modulators.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2004-07-09
Employees
4 (2026 accounts)
Registered office
22 Manchester Square, C/O Steinfeld Law Llp, London, England, W1U 3PT
Postcode
W1U 3PT
Capital
1,505 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2026-01-31
Next due by
2027-04-30
Financial year end
31 July

Confirmation statement

Last statement dated
2025-12-20
Next due by
2027-01-03
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 2 current · 18 resigned

Subscribers only Director
Subscribers only Appointed 2023-07-03
Subscribers only Director
Appointed 2023-05-10

View all officers and resignations →

Contact details

Website
http://www.bioeos.co.uk

Previous registered addresses 2

AddressChanged on
67 LAKERS RISE, WOODMANSTERNE, SURREY, SM7 3LA2011-03-10
16 ST JOHN STREET, LONDON, EC1M 4NT2004-08-19

Among its peers

2nd oldest

of 218 similar companies in W, trading since 2004

Competitors London

This company ranks 51 among research and experimental development on biotechnology in London.

Full league table →

The class of 2004

36%

of the 135,822 companies incorporated in 2004 are still active today; 61% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →